Voyager Therapeutics, Inc. (VYGR)
3.43
-0.02
(-0.58%)
USD |
NASDAQ |
Sep 01, 16:00
3.42
-0.01
(-0.29%)
After-Hours: 20:00
Voyager Therapeutics Debt to Equity Ratio : 0.211 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.211 |
| March 31, 2026 | 0.199 |
| December 31, 2025 | 0.1861 |
| September 30, 2025 | 0.1745 |
| June 30, 2025 | 0.1648 |
| March 31, 2025 | 0.154 |
| December 31, 2024 | 0.1459 |
| September 30, 2024 | 0.1373 |
| June 30, 2024 | 0.1399 |
| March 31, 2024 | 0.1406 |
| December 31, 2023 | 0.0859 |
| September 30, 2023 | 0.1193 |
| June 30, 2023 | 0.1092 |
| March 31, 2023 | 0.1034 |
| December 31, 2022 | 0.3918 |
| September 30, 2022 | 0.2978 |
| June 30, 2022 | 0.4041 |
| March 31, 2022 | 0.5646 |
| December 31, 2021 | 0.4648 |
| September 30, 2021 | 0.5177 |
| June 30, 2021 | 0.4136 |
| March 31, 2021 | 0.3431 |
| December 31, 2020 | 0.3085 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.1913 |
| June 30, 2020 | 0.4241 |
| March 31, 2020 | 0.4187 |
| December 31, 2019 | 0.3434 |
| September 30, 2019 | 0.3219 |
| June 30, 2019 | 0.2994 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
| Imunon, Inc. | 1.873 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 197.75M |
| Total Liabilities (Quarterly) | 43.38M |
| Shareholders Equity (Quarterly) | 154.38M |
| Current Ratio | 7.505 |
| Net Debt Paydown Yield | 0.88% |